Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2021-04-23 2021-04-23
Drug Identification Number 02399385 02399385
Brand name ATORVASTATIN ATORVASTATIN
Common or Proper name ATORVASTATIN ATORVASTATIN
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients ATORVASTATIN ATORVASTATIN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-04-22 2021-04-22
Remaining supply date 2021-04-22 2021-04-22
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Demand already transferred to 5760611112 pms-ATORVASTATIN 20mg TABS 100 Demand already transferred to 5760611112 pms-ATORVASTATIN 20mg TABS 100
Health Canada comments